News
Immune cell feedback drives thymus's complex architecture, new model reveals by Ludwig Maximilian University of Munich edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...
A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...
News & Views Published: August 2000 From parathyroid to thymus, via glial cells Rudi Balling & Reinhold G. Erben Nature Medicine 6, 860–861 (2000) Cite this article ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
News Medical on MSN6d
Timepoint at which B cells transform into leukemic cells impacts treatment outcomesNew findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...
Ibrahim Aldoss, MD, discusses the potential of AZD0486 for treating relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and outlines the SYRUS study objectives.
Session ID: 2025-07-02:4d5fa2e1d3ea57191fac9102 Player Element ID: V61ce242e_558c_447e_9107_acb9fd2d6e1d_6374466286112 ...
AZD0486 demonstrated encouraging safety and dose-dependent efficacy in heavily pretreated adolescent and adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), according to ...
Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347), evaluating epcoritamab, a T-cell engaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback